chr6-162026580-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004562.3(PRKN):c.618+27511A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,240 control chromosomes in the GnomAD database, including 2,169 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 2169 hom., cov: 32)
Consequence
PRKN
NM_004562.3 intron
NM_004562.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0650
Publications
4 publications found
Genes affected
PRKN (HGNC:8607): (parkin RBR E3 ubiquitin protein ligase) The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [provided by RefSeq, Jul 2008]
PRKN Gene-Disease associations (from GenCC):
- autosomal recessive juvenile Parkinson disease 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
- Parkinson diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- young-onset Parkinson diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.167 AC: 25433AN: 152122Hom.: 2171 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25433
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.167 AC: 25426AN: 152240Hom.: 2169 Cov.: 32 AF XY: 0.168 AC XY: 12497AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
25426
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
12497
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
5463
AN:
41528
American (AMR)
AF:
AC:
2872
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
756
AN:
3472
East Asian (EAS)
AF:
AC:
730
AN:
5188
South Asian (SAS)
AF:
AC:
1267
AN:
4824
European-Finnish (FIN)
AF:
AC:
1547
AN:
10606
Middle Eastern (MID)
AF:
AC:
72
AN:
292
European-Non Finnish (NFE)
AF:
AC:
12138
AN:
68012
Other (OTH)
AF:
AC:
400
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1081
2161
3242
4322
5403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
753
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.